Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New cannabinoid CB1/CB2 receptor ligands presented by Canopy Growth Corp.

Jan. 21, 2021

Preliminary topline phase II data for NSI-566 in ischemic stroke

Jan. 21, 2021

LMR-101 ameliorates symptoms of epilepsy in rodents

Jan. 20, 2021

GPR68-PKC pathway protects the brain from acidosis-induced neuronal injury

Jan. 20, 2021

Bayer synthesizes new P2X3 receptor antagonists

Jan. 20, 2021

Sobetirome and its prodrug show efficacy in models of EAE

Jan. 19, 2021

Biohaven presents focused analysis data from phase II/III study of troriluzole in AD

Jan. 19, 2021

Metrion and LifeArc extend neuroscience drug discovery collaboration

Jan. 18, 2021

Presenilin mutations affect neuronal stem cells

Jan. 18, 2021

PK/PD effect studies evaluating differences in clinical efficacy of LEO-29102 and LEO-39652

Jan. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...